Souhaitez-vous accéder aux communiqués récents ?

Cash and cash equivalents and restricted cash of $82.6 million as of March 31, 2026 — sufficient liquidity to execute across all three growth enginesCompleted the acquisition of Distributed...

Pivotal Phase 2 with lasme-cel in r/r B-ALL (BALLI-01 trial)  Pivotal Phase 2 first interim analysis expected in Q4 2026BLA submission anticipated in 2028 Phase 1 with eti-cel in r/r NHL (NATHALI-01...

GRAND CAYMAN, Cayman Islands, May 11, 2026 (GLOBE NEWSWIRE) -- Oxbridge Re Holdings Limited (NASDAQ: OXBR), (the “Company”), a leader in digitizing reinsurance securities as tokenized real-world...

MILWAUKEE, May 11, 2026 (GLOBE NEWSWIRE) -- Artisan Partners Asset Management Inc. (NYSE: APAM) today reported that its preliminary assets under management ("AUM") as of April 30, 2026 totaled...

First Quarter Net Sales of $128.6 millionFirst Quarter Net Income of $7.3 millionDiluted EPS of $0.32 for the Quarter WOOD DALE, Ill., May 11, 2026 (GLOBE NEWSWIRE) -- Power Solutions...

First Quarter 2026 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $52.6 million, representing growth of 11.2%U.S. revenue of $49.3 million, representing...

Annual subscription revenue rose to 57.4% of total revenue in Q1Corporate, now over 60% of total revenue, continues to grow, up nearly 6% year over yearCompany maintains full-year 2026 revenue and...

COLUMBIA, Md., May 11, 2026 (GLOBE NEWSWIRE) -- Rekor Systems, Inc. (NASDAQ: REKR) ("Rekor" or the "Company"), a leader in AI-powered roadway intelligence, today reported financial and operational...

NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- Kaltura, Inc. (Nasdaq: KLTR, “Kaltura” or the “Company”), the Agentic Digital Experience company, today announced financial results for the first quarter...

Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results